A biopharmaceutical company based in Dallas is set to be acquired. The acquisition price is over $2 billion. Further information about the acquisition can be found through the Dallas News.

Details about the company and the acquisition are available from this source. The Dallas News is the source for more information on this development, providing additional context and details about the acquisition of the Dallas biopharmaceutical company.